Stuart Sprague to Calcifediol
This is a "connection" page, showing publications Stuart Sprague has written about Calcifediol.
Connection Strength
1.516
-
Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease. Am J Nephrol. 2016; 44(4):316-325.
Score: 0.584
-
Modified-release calcifediol effectively controls secondary hyperparathyroidism associated with vitamin D insufficiency in chronic kidney disease. Am J Nephrol. 2014; 40(6):535-45.
Score: 0.518
-
Bone disease after kidney transplantation. Semin Nephrol. 2004 Jan; 24(1):82-90.
Score: 0.241
-
Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease. Am J Nephrol. 2019; 49(4):284-293.
Score: 0.173